After decades of research and two previous drug development attempts, things are looking promising for a team of University of Arizona researchers working on a less toxic treatment for a specific type of breast cancer.
University of Arizona researchers have developed a drug that shows signs of eliminating triple-negative breast cancer in mice with little to no toxic side effects. Next, it goes to phase 1 clinical trials in humans.